Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).

dc.contributor.authorAkyildiz, Arif
dc.contributor.authorGuven, Deniz Can
dc.contributor.authorKoksal, Baris
dc.contributor.authorKaraoglan, Beliz Bahar
dc.contributor.authorSalim, Derya Kivrak
dc.contributor.authorSutcuoglu, Osman
dc.contributor.authorAksoy, Sercan
dc.date.accessioned2026-08-12T18:13:03Z
dc.date.issued2024
dc.departmentFırat Üniversitesi
dc.descriptionSpecial Clinical Science Symposia -- MAY 29-29, 2024 -- ELECTR NETWORK
dc.description.abstract[Abstract Not Available]
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue16
dc.identifier.urihttps://hdl.handle.net/11508/64188
dc.identifier.volume42
dc.identifier.wosWOS:001275557404771
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleReal-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).
dc.typeConference Object

Dosyalar